Entera Bio Ltd. Forecast, price target & analysts
Entera Bio Ltd. Target price 2025 - Analyst rating & recommendation
Entera Bio Ltd. Classifications & Recommendation:
Entera Bio Ltd. Price Target
| Target Price | $10.20 |
| Price | $2.22 |
| Potential |
359.46%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Entera Bio Ltd. 2026 .
The average Entera Bio Ltd. target price is $10.20.
This is
359.46%
register free of charge
$10.50
372.97%
register free of charge
$10.10
354.95%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Entera Bio Ltd. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Entera Bio Ltd. stock has an average upside potential 2026 of
359.46%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.18 | 0.04 |
| 76.22% | ||
| Net Margin | -5,300.00% | -34,628.57% |
| 553.37% |
3 Analysts have issued a sales forecast Entera Bio Ltd. 2025 . The average Entera Bio Ltd. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $180k | |
|---|---|---|
| 2025 |
$42.8k
76.22%
Unlock
|
|
3 Entera Bio Ltd. Analysts have issued a net profit forecast 2025. The average Entera Bio Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Margin
| 2024 | -5,300.00% | |
|---|---|---|
| 2025 |
-34,628.57%
553.37%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.25 | -0.33 |
| 19.35% | 32.00% | |
| P/E | negative | |
| EV/Sales | 2,112.75 |
3 Analysts have issued a Entera Bio Ltd. forecast for earnings per share. The average Entera Bio Ltd. EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Entera Bio Ltd. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 532.43 | 11.67% |
|---|---|---|
| 2025 |
2,112.75
296.81%
Unlock
|
|
P/S ratio
| Current | 596.31 | 11.26% |
|---|---|---|
| 2025 |
2,366.25
296.81%
Unlock
|
|
Entera Bio Ltd....
Current Entera Bio Ltd. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 11 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 27 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 11 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 07 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 27 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
